Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Yangqing Zhan"'
Autor:
Ye Qiu, Hao Wen, Haoru Wang, Wenjun Sun, Guangchao Li, Shaoqiang Li, Yan Wang, Jingnan Zhai, Yangqing Zhan, Yutian Su, Zhiwei Long, Zhengtu Li, Feng Ye
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundNirmatrelvir-ritonavir (Paxlovid) has received emergency use authorization from the US Food and Drug Administration owing to its effectiveness and safety. However, data on the effectiveness and safety of Paxlovid use in COVID-19 patients wi
Externí odkaz:
https://doaj.org/article/d9c88b27c5c94e1b833b8480ffd79753
Autor:
Zhiqi Zeng, Qianying Li, Hua Guo, Yong Liu, Lixi Liang, Yuanfang Lai, Yi Fang, Lei Li, Qiuting Xue, Yangqing Zhan, Zhengshi Lin, Wenda Guan, Zifeng Yang
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 14 (2024)
BackgroundAccurate detection of influenza virus in clinical samples requires correct execution of all aspects of the detection test. If the viral load in a sample is below the detection limit, a false negative result may be obtained. To overcome this
Externí odkaz:
https://doaj.org/article/707b2343adb643b88c6727b92a9aaa2b
Autor:
Hongzhou Lu, George Zhang, John Mao, Xiaochun Chen, Yangqing Zhan, Ling Lin, Tianxiang Zhang, Yanan Tang, Feng Lin, Feiyue Zhu, Yuanlong Lin, Yiming Zeng, Kaiyu Zhang, Wenfang Yuan, Zhenyu Liang, Ruilin Sun, Liya Huo, Peng Hu, Yihua Lin, Xibin Zhuang, Zhaohui Wei, Xia Chen, Wenhao Yan, Xiuping Yan, Lisa Mu, Zhuhua Lin, Xinyu Tu, Hongshan Tan, Fuhu Huang, Zhiqiang Hu, Hongming Li, Guoping Li, Haijun Fu, Zifeng Yang, Xinwen Chen, Fu-Sheng Wang, Nanshan Zhong
Publikováno v:
EClinicalMedicine, Vol 71, Iss , Pp 102582- (2024)
Summary: Background: GST-HG171 is a potent, broad-spectrum, orally bioavailable small-molecule 3C like protease inhibitor that has demonstrated greater potency and efficacy compared to Nirmatrelvir in pre-clinical studies. We aimed to evaluate the ef
Externí odkaz:
https://doaj.org/article/ee8f6c83fea04bdfa8bcbfb122e1bceb
Autor:
Xidong Wang, Shaoqiang Li, Mangui Zhu, Ye Qiu, Yilei Hui, Yongming Li, Yangqing Zhan, Yan Wang, Feng Ye, Zhengtu Li
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background/Objective With the development of society, pulmonary fungal diseases, represented by pulmonary aspergillosis and pulmonary cryptococcosis, have become increasingly common. However, there is a lack of clear understanding regarding
Externí odkaz:
https://doaj.org/article/bf1da58b6f154e5ca5f9e434e27410ed
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Reducing current clinical symptoms and the risks of future exacerbations is the main goal of stable COPD management. Traditional Chinese medicine has unique advantages in chronic disease management. YuPingFeng (YPF), as a classica
Externí odkaz:
https://doaj.org/article/d75fc8cb659044548503e4b661853c42
Autor:
Zhiwei Long, Xiaotong Li, Zhengtu Li, Jieying Hu, Ye Qiu, Shaoqiang Li, Yangqing Zhan, Feng Ye, Yan Wang
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 14 (2024)
BackgroundThe prevalence of invasive pulmonary aspergillosis (IPA) among patients with chronic obstructive pulmonary disease (COPD) is steadily increasing, leading to high mortality. Although early diagnosis can significantly reduce mortality, the ef
Externí odkaz:
https://doaj.org/article/d057c1d7fff14fa4956ca88013a76522
Publikováno v:
Journal of International Medical Research, Vol 52 (2024)
Objectives We assessed the efficacy of a 3-week primary or salvage caspofungin regimen in patients with chronic obstructive pulmonary disease (COPD) and concomitant proven or suspected invasive pulmonary aspergillosis (IPA). Methods Forty-four patien
Externí odkaz:
https://doaj.org/article/afcc6b52c97a4657a69ac756c5dba2f7
Autor:
Yangqing Zhan, Zhengshi Lin, Jingyi Liang, Ruilin Sun, Yueping Li, Bingliang Lin, Fangqi Ge, Ling Lin, Hongzhou Lu, Liang Su, Tianxin Xiang, Hongqiu Pan, Chaolin Huang, Ying Deng, Furong Wang, Ruhong Xu, Dexiong Chen, Ping Zhang, Jianlin Tong, Xifu Wang, Qingwei Meng, Zhigang Zheng, Shuqiang Ou, Xiaoyun Guo, Herui Yao, Tao Yu, Weiyang Li, Yu Zhang, Mei Jiang, Zhonghao Fang, Yudi Song, Ruifeng Chen, Jincan Luo, Changyuan Kang, Shiwei Liang, Haijun Li, Jingping Zheng, Nanshan Zhong, Zifeng Yang, Huang Yanming, M.M, Dong Haiping, M.D., Jinlin Hou, M.M, Shao Lei, M.D., Li Xiaoguang, M.D., Gao Yan, M.M.
Publikováno v:
EClinicalMedicine, Vol 67, Iss , Pp 102359- (2024)
Summary: Background: Leritrelvir is a novel α-ketoamide based peptidomimetic inhibitor of SARS-CoV-2 main protease. A preclinical study has demonstrated leritrelvir poses similar antiviral activities towards different SARS-CoV-2 variants compared wi
Externí odkaz:
https://doaj.org/article/47dbfffb279a4d67b276d3a4042f438c
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 24, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/aadb266eecf34944b05426cb3123a581
Autor:
Zhengtu Li, Yongming Li, Shaoqiang Li, Zhun Li, Ying Mai, Jing Cheng, Danhong Su, Yangqing Zhan, Nanshan Zhong, Feng Ye
Publikováno v:
Emerging Microbes and Infections, Vol 11, Iss 1, Pp 1346-1355 (2022)
A previously unknown Nocardia species was isolated from the lung tissue and bronchoalveolar lavage fluid (BALF) of a 58-year-old woman with bronchiectasis and recurrent pneumonia. This Nocardia (GZ2020T), which grew readily in Columbia blood agar and
Externí odkaz:
https://doaj.org/article/5587ce5ff90843cf9deb0575956b36b6